Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C W Edwards

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Best Practice & Research. Clinical Rheumatology|September 19, 2006
B cell depletion therapy in rheumatic diseaseJ C W Edwards, G Cambridge, M J Leandro
Rheumatic Diseases Clinics of North America|June 3, 2004
B lymphocyte depletion therapy with rituximab in rheumatoid arthritisJ C W Edwards, M J Leandro, G Cambridge
Biochemical Society Transactions|August 28, 2002
B-lymphocyte depletion therapy in rheumatoid arthritis and other autoimmune disordersJ C W Edwards, M J Leandro, G Cambridge
Annals of the Rheumatic Diseases|September 14, 2002
Clinical outcome in 22 patients with rheumatoid arthritis treated with B lymphocyte depletionM J Leandro, J C W Edwards, G Cambridge
Rheumatology (Oxford, England)|December 26, 2006
Repeated B lymphocyte depletion with rituximab in rheumatoid arthritis over 7 yrsC Popa, M J Leandro, G Cambridge, et al.
Arthritis and Rheumatism|July 13, 2002
Macrophage subpopulations in rheumatoid synovium: reduced CD163 expression in CD4+ T lymphocyte-rich microenvironmentsJ E Fonseca, J C W Edwards, S Blades, et al.
Rheumatology (Oxford, England)|June 1, 2006
Bone marrow B-lineage cells in patients with rheumatoid arthritis following rituximab therapyM J Leandro, N Cooper, G Cambridge, et al.
Clinical and Experimental Rheumatology|November 27, 2008
Clinical outcome following B cell depletion therapy in eight patients with refractory idiopathic inflammatory myopathyS M Sultan, K P Ng, J C W Edwards, et al.
Annals of the Rheumatic Diseases|October 2, 2007
B cell depletion therapy for patients with systemic lupus erythematosus results in a significant drop in anticardiolipin antibody titresY Ioannou, A Lambrianides, G Cambridge, et al.
Annals of the Rheumatic Diseases|October 27, 2007
B cell depletion therapy in systemic lupus erythematosus: relationships among serum B lymphocyte stimulator levels, autoantibody profile and clinical responseG Cambridge, D A Isenberg, J C W Edwards, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Best Practice & Research. Clinical Rheumatology|September 19, 2006
B cell depletion therapy in rheumatic diseaseJ C W Edwards, G Cambridge, M J Leandro
Rheumatic Diseases Clinics of North America|June 3, 2004
B lymphocyte depletion therapy with rituximab in rheumatoid arthritisJ C W Edwards, M J Leandro, G Cambridge
Biochemical Society Transactions|August 28, 2002
B-lymphocyte depletion therapy in rheumatoid arthritis and other autoimmune disordersJ C W Edwards, M J Leandro, G Cambridge
Annals of the Rheumatic Diseases|September 14, 2002
Clinical outcome in 22 patients with rheumatoid arthritis treated with B lymphocyte depletionM J Leandro, J C W Edwards, G Cambridge
Rheumatology (Oxford, England)|December 26, 2006
Repeated B lymphocyte depletion with rituximab in rheumatoid arthritis over 7 yrsC Popa, M J Leandro, G Cambridge, et al.
Arthritis and Rheumatism|July 13, 2002
Macrophage subpopulations in rheumatoid synovium: reduced CD163 expression in CD4+ T lymphocyte-rich microenvironmentsJ E Fonseca, J C W Edwards, S Blades, et al.
Rheumatology (Oxford, England)|June 1, 2006
Bone marrow B-lineage cells in patients with rheumatoid arthritis following rituximab therapyM J Leandro, N Cooper, G Cambridge, et al.
Clinical and Experimental Rheumatology|November 27, 2008
Clinical outcome following B cell depletion therapy in eight patients with refractory idiopathic inflammatory myopathyS M Sultan, K P Ng, J C W Edwards, et al.
Annals of the Rheumatic Diseases|October 2, 2007
B cell depletion therapy for patients with systemic lupus erythematosus results in a significant drop in anticardiolipin antibody titresY Ioannou, A Lambrianides, G Cambridge, et al.
Annals of the Rheumatic Diseases|October 27, 2007
B cell depletion therapy in systemic lupus erythematosus: relationships among serum B lymphocyte stimulator levels, autoantibody profile and clinical responseG Cambridge, D A Isenberg, J C W Edwards, et al.
Pageof 2